IMCC · IM Cannabis Corp.
Market Cap
$3.13M
Shares
1.65M
Volume · Oct 7
111.2K
Avg daily vol (29 sessions)
5.9M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$1.90
Open$1.90
Day$1.83–1.94
52W close$1.63–60.60
Avg vol 30d5.7M
Short int45K · 2.8% float · 1.0d
Short vol51%
DataMay 2020–Oct 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
-13.9%
Year over year
Operating margin
-21.2%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+91.1%
Year over year · more shares
Price change (1Y)
—
Trailing year
Short interest
2.8%
Latest settlement · 1.0 days to cover
Equibles Rating
blended score · not investment adviceOverall
Strong Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 15.1 · calm
Equity put/call 0.63
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−87%
below
Price vs 50-day avg
−35%
below
RSI (14)
42
neutral
MACD trend
Negative
52-week position
0%
near low
Volume (OBV)
Bullish div.
accumulating
Momentum
relative strength
1-month return
−5%
trailing
6-month return
−83%
trailing
YTD return
−95%
this year
Relative strength
−94%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $3 › 200d $15 — 200d above 50d
Institutional flow
Accumulating
+30% holders QoQ · +4 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
2.76% of float · ▲ +262.1% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
13 holders — mid 3-yr range
Squeeze score
53
elevated · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
192%
annualized · 1-yr
Max drawdown
−97%
past year
ATR
32.5%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−87%
Bearish
Price vs 50-day avg
−35%
Bearish
RSI (14)
42
Neutral
MACD trend
Negative
Bearish
52-week position
0%
Bearish
Volume (OBV)
Bullish div.
Bullish
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $3 › 200d $15 — 200d above 50d
Institutional flow
Accumulating
+30% holders QoQ · +4 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
2.76% of float · ▲ +262.1% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
13 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $2
Now $2 · 0%
Range high $61
vs 200-day avg -87%
vs 50-day avg -35%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Drug Manufacturers - Specialty & Generic — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
IMCC
this stock
IM Cannabis Corp.
|
$3.13M | — | — | — | 2.8% |
|
TAK
Takeda Pharmaceutical Co Ltd
|
$58.68B | +17.8% | — | — | 0.1% |
|
TEVA
Teva Pharmaceutical Industries Ltd
|
$45.66B | +25.5% | +4.3% | 64.2 | 2.7% |
|
GALDY
Galderma Group AG/ADR
|
$45.54B | -5.8% | — | — | 0.0% |
|
JHPCY
Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
|
$41.48B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| IMCC | -15.6% | -4.5% | -83.5% | -15.6% | -95.4% |
| SPY | +1.9% | +1.9% | +10.8% | +1.9% | +14.0% |
| vs SPY | -17.5% | -6.5% | -94.2% | -17.5% | -109.4% |